According to http://www.gurufocus.com/52weeklow.php]GuruFocus updates[/url], these Guru stocks have reached their 52-Week Highs: Johnson & Johnson (JNJ, Financial), McDonald's Corp. (MCD, Financial), British American Tobacco PLC (BTI, Financial), and AstraZeneca PLC (AZN, Financial).
Johnson & Johnson (JNJ) Reached the 52-Week High of $63.2
Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. The company's worldwide business is divided into three segments: Consumer; Pharmaceutical; and Professional. Johnson & Johnson has a market cap of $174.38 billion; its shares were traded at around $63.2 with a P/E ratio of 13.9 and P/S ratio of 2.7. The dividend yield of Johnson & Johnson stocks is 3.1%. Johnson & Johnson had an annual average earning growth of 12.5% over the past 10 years. GuruFocus rated Johnson & Johnson the business predictability rank of 5-star.
On October 13, Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Net earnings and diluted earnings per share for the third quarter of 2009 were $3.3 billion and $1.20, respectively, representing increases of 1.1% and 2.6%, as compared to the same period in 2008.
Johnson & Johnson is in the portfolios of Prem Watsa of Fairfax Financial Holdings, Inc., Jeremy Grantham of GMO LLC, Warren Buffett of Berkshire Hathaway, Bill Frels of MAIRS & POWER INC, Richard Perry of Perry Capital, Tweedy Browne of Tweedy Browne CO LLC, Tom Gayner of Markel Gayner Asset Management Corp, John Hussman of Hussman Economtrics Advisors, Inc., Donald Yacktman of Yacktman Asset Management Co., Chris Davis of Davis Selected Advisers, Diamond Hill Capital of Diamond Hill Capital Management Inc, Robert Olstein of Olstein Financial Alert Fund, Manning & Napier Advisors, Inc, Manning & Napier Advisors, Inc, Manning & Napier Advisors, Inc, Kenneth Fisher of Fisher Asset Management, LLC, Richard Pzena of Pzena Investment Management LLC, Bill Nygren of Oak Mark Fund, Brian Rogers of T Rowe Price Equity Income Fund, Brian Rogers of T Rowe Price Equity Income Fund, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Michael Price of MFP Investors LLC, John Buckingham of Al Frank Asset Management, Inc., Edward Owens of Vanguard Health Care Fund, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, Mark Hillman of Hillman Capital Management, PRIMECAP Management, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Tom Russo of Gardner Russo & Gardner, Murray Stahl of Horizon Asset Management, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, Arnold Van Den Berg of Century Management, George Soros of Soros Fund Management LLC, Richard Aster Jr of Meridian Fund, Dodge & Cox, and Richard Snow of Snow Capital Management, L.P..
Buy:: Director William D Perez bought 1,000 shares of JNJ stock in August.Sell:: VP, Human Resources Kaye I Foster-cheek and Sell:: Director James Cullen sold shares in December; Sell:: VP, General Counsel Russell C Deyo and Sell:: Member, Executive Committee Sherilyn S Mccoy sold shares in November.
McDonald's Corporation develops, operates, franchises and services a worldwide system of restaurants that prepare, assemble, package and sell a limited menu of value-priced foods. The company operates primarily in the quick-service hamburger restaurant business. All restaurants are operated by the company or, under the terms of franchise arrangements, by franchisees who are independent third parties, or by affiliates operating under joint-venture agreements between the company and local business people. Mcdonald's Corp. has a market cap of $68.41 billion; its shares were traded at around $63.39 with a P/E ratio of 16.5 and P/S ratio of 2.9. The dividend yield of Mcdonald's Corp. stocks is 3.5%. Mcdonald's Corp. had an annual average earning growth of 7.2% over the past 10 years.
On January 22, McDonald’s Corp. reported results for the fourth quarter of 2009. Results included global comparable sales increase of 3.8%, fueled by the U.S. 2.6%, Europe 5.2% and Asia/Pacific, Middle East and Africa 3.4%, growth in McDonald's combined operating margin to 30.1%, and consolidated operating income increase of 6% (10% in constant currencies) over the prior year
McDonald’s Corp. is in the portfolios of Bill Ackman of Pershing Square Capital Management, L.P., Steve Mandel of Lone Pine Capital, Bill Gates of Bill & Melinda Gates Foundation Trust, Diamond Hill Capital of Diamond Hill Capital Management Inc, Robert Olstein of Olstein Financial Alert Fund, Bill Nygren of Oak Mark Fund, David Winters of Wintergreen Advisors, Chase Coleman of TIGER GLOBAL MANAGEMENT LLC, Jeremy Grantham of GMO LLC, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Tom Gayner of Markel Gayner Asset Management Corp, John Buckingham of Al Frank Asset Management, Inc., Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Paul Tudor Jones of The Tudor Group, Manning & Napier Advisors, Inc, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, Manning & Napier Advisors, Inc, Manning & Napier Advisors, Inc, Stanley Druckenmiller of Duquesne Capital Management, LLC, Tom Russo of Gardner Russo & Gardner, Bill Frels of MAIRS & POWER INC, Dodge & Cox, Ron Baron of Baron Funds, Richard Aster Jr of Meridian Fund, Murray Stahl of Horizon Asset Management, and George Soros of Soros Fund Management LLC.
In August, Buy:: Director John W Jr Rogers bought 500 shares of MCD stock and the price has increased over 15% since. In December, Sell:: President and COO Ralph Alvarez and Sell:: Director Jeanne P Jackson sold shares; in November, Sell:: President, McDonald's USA Donald Thompson and Sell:: President, McDonald's APMEA Timothy J Fenton sold shares.
British American Tobacco is the holding company of a group of companies which manufacture, market and sell tobacco products. British American Tobacco Plc has a market cap of $66.23 billion; its shares were traded at around $65.71 with and P/S ratio of 2.9. The dividend yield of British American Tobacco Plc stocks is 4.2%. British American Tobacco Plc had an annual average earning growth of 13.1% over the past 10 years.
On October 28, British American Tobacco reported results for the nine months ended September 30, 2009. Results included strong revenue growth at both constant and current exchange rates, and volume from subsidiaries increased at 2% to 533 billion.
British American Tobacco PLC is in the portfolios of Sarah Ketterer of Causeway Capital Management.
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services. Astrazeneca Plc has a market cap of $70.79 billion; its shares were traded at around $48.84 with a P/E ratio of 8.4 and P/S ratio of 2.3. The dividend yield of Astrazeneca Plc stocks is 4.3%. Astrazeneca Plc had an annual average earning growth of 12.2% over the past 10 years. GuruFocus rated Astrazeneca Plc the business predictability rank of 2-star.
On October 29, AstraZeneca posted results for the nine months ended September 30, 2009. Pharmaceutical company AstraZeneca PLC posted a 22 percent rise in third quarter net profit on Thursday, boosted by initial sales of its swine flu vaccine and delayed entry of generic drug competition in the United States.
AstraZeneca PLC is in the portfolios of Edward Owens of Vanguard Health Care Fund, John Hussman of Hussman Economtrics Advisors, Inc., Charles Brandes of Brandes Investment, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates, Kenneth Fisher of Fisher Asset Management, LLC, and John Buckingham of Al Frank Asset Management, Inc.
Johnson & Johnson (JNJ) Reached the 52-Week High of $63.2
Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. The company's worldwide business is divided into three segments: Consumer; Pharmaceutical; and Professional. Johnson & Johnson has a market cap of $174.38 billion; its shares were traded at around $63.2 with a P/E ratio of 13.9 and P/S ratio of 2.7. The dividend yield of Johnson & Johnson stocks is 3.1%. Johnson & Johnson had an annual average earning growth of 12.5% over the past 10 years. GuruFocus rated Johnson & Johnson the business predictability rank of 5-star.
On October 13, Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Net earnings and diluted earnings per share for the third quarter of 2009 were $3.3 billion and $1.20, respectively, representing increases of 1.1% and 2.6%, as compared to the same period in 2008.
Johnson & Johnson is in the portfolios of Prem Watsa of Fairfax Financial Holdings, Inc., Jeremy Grantham of GMO LLC, Warren Buffett of Berkshire Hathaway, Bill Frels of MAIRS & POWER INC, Richard Perry of Perry Capital, Tweedy Browne of Tweedy Browne CO LLC, Tom Gayner of Markel Gayner Asset Management Corp, John Hussman of Hussman Economtrics Advisors, Inc., Donald Yacktman of Yacktman Asset Management Co., Chris Davis of Davis Selected Advisers, Diamond Hill Capital of Diamond Hill Capital Management Inc, Robert Olstein of Olstein Financial Alert Fund, Manning & Napier Advisors, Inc, Manning & Napier Advisors, Inc, Manning & Napier Advisors, Inc, Kenneth Fisher of Fisher Asset Management, LLC, Richard Pzena of Pzena Investment Management LLC, Bill Nygren of Oak Mark Fund, Brian Rogers of T Rowe Price Equity Income Fund, Brian Rogers of T Rowe Price Equity Income Fund, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Michael Price of MFP Investors LLC, John Buckingham of Al Frank Asset Management, Inc., Edward Owens of Vanguard Health Care Fund, John Rogers of ARIEL CAPITAL MANAGEMENT LLC, Mark Hillman of Hillman Capital Management, PRIMECAP Management, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Tom Russo of Gardner Russo & Gardner, Murray Stahl of Horizon Asset Management, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, Arnold Van Den Berg of Century Management, George Soros of Soros Fund Management LLC, Richard Aster Jr of Meridian Fund, Dodge & Cox, and Richard Snow of Snow Capital Management, L.P..
Buy:: Director William D Perez bought 1,000 shares of JNJ stock in August.Sell:: VP, Human Resources Kaye I Foster-cheek and Sell:: Director James Cullen sold shares in December; Sell:: VP, General Counsel Russell C Deyo and Sell:: Member, Executive Committee Sherilyn S Mccoy sold shares in November.
McDonald's Corporation develops, operates, franchises and services a worldwide system of restaurants that prepare, assemble, package and sell a limited menu of value-priced foods. The company operates primarily in the quick-service hamburger restaurant business. All restaurants are operated by the company or, under the terms of franchise arrangements, by franchisees who are independent third parties, or by affiliates operating under joint-venture agreements between the company and local business people. Mcdonald's Corp. has a market cap of $68.41 billion; its shares were traded at around $63.39 with a P/E ratio of 16.5 and P/S ratio of 2.9. The dividend yield of Mcdonald's Corp. stocks is 3.5%. Mcdonald's Corp. had an annual average earning growth of 7.2% over the past 10 years.
On January 22, McDonald’s Corp. reported results for the fourth quarter of 2009. Results included global comparable sales increase of 3.8%, fueled by the U.S. 2.6%, Europe 5.2% and Asia/Pacific, Middle East and Africa 3.4%, growth in McDonald's combined operating margin to 30.1%, and consolidated operating income increase of 6% (10% in constant currencies) over the prior year
McDonald’s Corp. is in the portfolios of Bill Ackman of Pershing Square Capital Management, L.P., Steve Mandel of Lone Pine Capital, Bill Gates of Bill & Melinda Gates Foundation Trust, Diamond Hill Capital of Diamond Hill Capital Management Inc, Robert Olstein of Olstein Financial Alert Fund, Bill Nygren of Oak Mark Fund, David Winters of Wintergreen Advisors, Chase Coleman of TIGER GLOBAL MANAGEMENT LLC, Jeremy Grantham of GMO LLC, HOTCHKIS & WILEY of HOTCHKIS & WILEY Capital Management LLC, Tom Gayner of Markel Gayner Asset Management Corp, John Buckingham of Al Frank Asset Management, Inc., Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Paul Tudor Jones of The Tudor Group, Manning & Napier Advisors, Inc, Ruane Cunniff of Ruane & Cunniff & Goldfarb Inc, Manning & Napier Advisors, Inc, Manning & Napier Advisors, Inc, Stanley Druckenmiller of Duquesne Capital Management, LLC, Tom Russo of Gardner Russo & Gardner, Bill Frels of MAIRS & POWER INC, Dodge & Cox, Ron Baron of Baron Funds, Richard Aster Jr of Meridian Fund, Murray Stahl of Horizon Asset Management, and George Soros of Soros Fund Management LLC.
In August, Buy:: Director John W Jr Rogers bought 500 shares of MCD stock and the price has increased over 15% since. In December, Sell:: President and COO Ralph Alvarez and Sell:: Director Jeanne P Jackson sold shares; in November, Sell:: President, McDonald's USA Donald Thompson and Sell:: President, McDonald's APMEA Timothy J Fenton sold shares.
British American Tobacco is the holding company of a group of companies which manufacture, market and sell tobacco products. British American Tobacco Plc has a market cap of $66.23 billion; its shares were traded at around $65.71 with and P/S ratio of 2.9. The dividend yield of British American Tobacco Plc stocks is 4.2%. British American Tobacco Plc had an annual average earning growth of 13.1% over the past 10 years.
On October 28, British American Tobacco reported results for the nine months ended September 30, 2009. Results included strong revenue growth at both constant and current exchange rates, and volume from subsidiaries increased at 2% to 533 billion.
British American Tobacco PLC is in the portfolios of Sarah Ketterer of Causeway Capital Management.
AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services. Astrazeneca Plc has a market cap of $70.79 billion; its shares were traded at around $48.84 with a P/E ratio of 8.4 and P/S ratio of 2.3. The dividend yield of Astrazeneca Plc stocks is 4.3%. Astrazeneca Plc had an annual average earning growth of 12.2% over the past 10 years. GuruFocus rated Astrazeneca Plc the business predictability rank of 2-star.
On October 29, AstraZeneca posted results for the nine months ended September 30, 2009. Pharmaceutical company AstraZeneca PLC posted a 22 percent rise in third quarter net profit on Thursday, boosted by initial sales of its swine flu vaccine and delayed entry of generic drug competition in the United States.
AstraZeneca PLC is in the portfolios of Edward Owens of Vanguard Health Care Fund, John Hussman of Hussman Economtrics Advisors, Inc., Charles Brandes of Brandes Investment, Paul Tudor Jones of The Tudor Group, Bruce Kovner of Caxton Associates, Kenneth Fisher of Fisher Asset Management, LLC, and John Buckingham of Al Frank Asset Management, Inc.
Become a Premium Member to See This: (Free Trial):
